These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 18271296)

  • 1. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
    Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A
    Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of potential impurities of quetiapine fumarate.
    Stolarczyk EU; Kaczmarek L; Eksanow K; Kubiszewski M; Glice M; Kutner A
    Pharm Dev Technol; 2009; 14(1):27-37. PubMed ID: 18815940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of new impurity in didanosine.
    Srinivasa Rao DV; Srinivas N; Bharathi Ch; Prasad ChS; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Nov; 45(3):516-20. PubMed ID: 17624711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
    Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
    J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural identification and characterization of impurities in ceftizoxime sodium.
    Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of potential impurities of amlodipine maleate.
    Sudhakar P; Nirmala M; Moses Babu J; Vyas K; Madhusudan Reddy G; Vijaya Bhaskar B; Pratap Reddy P; Mukkanti K
    J Pharm Biomed Anal; 2006 Feb; 40(3):605-13. PubMed ID: 16324814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate.
    Raj TJ; Bharathi Ch; Kumar MS; Prabahar J; Kumar PN; Sharma HK; Parikh K
    J Pharm Biomed Anal; 2009 Jan; 49(1):156-62. PubMed ID: 19056198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of potential impurities of donepezil.
    Krishna Reddy KV; Moses Babu J; Kumar PA; Chandrashekar ER; Mathad VT; Eswaraiah S; Reddy MS; Vyas K
    J Pharm Biomed Anal; 2004 Sep; 35(5):1047-58. PubMed ID: 15336352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification, isolation and characterization of potential degradation products in pioglitazone hydrochloride drug substance.
    Ramulu K; Kumar TT; Krishna SR; Vasudev R; Kaviraj M; Rao BM; Rao NS
    Pharmazie; 2010 Mar; 65(3):162-8. PubMed ID: 20383934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural identification and characterization of impurities in moxifloxacin.
    Kumar YR; Prasad Raju VV; Kumar RR; Eswaraiah S; Mukkanti K; Suryanarayana MV; Reddy MS
    J Pharm Biomed Anal; 2004 Mar; 34(5):1125-9. PubMed ID: 15019047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies of racecadotril and its process impurities by NMR and mass spectroscopy.
    Reddy KM; Babu JM; Sudhakar P; Sharma MS; Reddy GS; Vyas K
    Pharmazie; 2006 Dec; 61(12):994-8. PubMed ID: 17283655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characterization of impurities in pioglitazone.
    Kumar YR; Reddy AR; Eswaraiah S; Mukkanti K; Reddy MS; Suryanarayana MV
    Pharmazie; 2004 Nov; 59(11):836-9. PubMed ID: 15587582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium.
    Saravanan M; Siva Kumari K; Pratap Reddy P; Naidu MN; Moses Babu J; Srivastava AK; Lakshmi Kumar T; Chandra Sekhar BV; Satyanarayana B
    J Pharm Biomed Anal; 2008 Nov; 48(3):708-15. PubMed ID: 18755563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
    Thomas S; Mathela CS; Agarwal A; Paul SK
    J Pharm Biomed Anal; 2011 Sep; 56(2):423-8. PubMed ID: 21676571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and structural identification of an impurity in fluconazole bulk drug substance.
    Dongre VG; Ghugare PD; Karmuse PP; Soudagar SR; Panda N; Kumar A
    J Pharm Biomed Anal; 2007 Nov; 45(3):422-9. PubMed ID: 17706390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of new impurities in rivastigmine.
    Srinivasa Rao M; Rao SV; Srinivasa Rao DV; Bharathi Ch; Rajput P; Sharma HK
    Pharmazie; 2010 May; 65(5):336-8. PubMed ID: 20503924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist.
    Sampath A; Reddy AR; Yakambaram B; Thirupathi A; Prabhakar M; Reddy PP; Reddy VP
    J Pharm Biomed Anal; 2009 Oct; 50(3):405-12. PubMed ID: 19560892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, isolation, and characterization of potential degradation products in a triple combination lamivudine, zidovudine, and nevirapine tablet for oral suspension.
    Aparna P; Rao SV; Thomas KM; Mukkanti K; Badarinadh Gupta P; Rangarao K; Narayan GK; Sandip T; Upendra K
    Pharmazie; 2010 May; 65(5):331-5. PubMed ID: 20503923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.